The field moves faster when the people building it are connected to the people using it.
Global Oncology AI Consortium
Clinical AI only works if the people who use it helped shape it. The field has no shortage of tools built in isolation from the clinicians expected to trust them.
The Global Oncology AI Consortium was founded to change that. It brings together radiation oncology teams and AI builders to develop solutions collaboratively, grounded in real-world clinical insight, validated across institutions, and designed to hold up in practice, not just in pilots.
Built on a formal organizational blueprint and scalability model. Currently leading the consortium through its active formation across founding member institutions globally.
CancerX
CancerX is a national initiative accelerating innovation at the intersection of cancer care and technology. As a mentor, the focus is on helping early-stage oncology innovators build with clinical credibility, understanding what the field actually needs and what responsible deployment looks like in practice.
Angel Investor
Selectively investing in early-stage healthcare companies working on problems worth solving. The criteria are simple: real clinical problem, credible team, defensible approach to AI that doesn't cut corners on governance or evidence.
Advisor
Advising healthcare and health tech companies on AI strategy, product development, and responsible deployment in regulated clinical environments. Particular focus on organizations building at the intersection of AI and oncology.
Connect
If any of these intersect with work you're doing, the contact page is the right next step.